These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15684403)

  • 1. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO modification modulates the transrepression activity of PLZF.
    Chao TT; Chang CC; Shih HM
    Biochem Biophys Res Commun; 2007 Jun; 358(2):475-82. PubMed ID: 17498654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation of CoREST modulates its function as a transcriptional repressor.
    Muraoka A; Maeda A; Nakahara N; Yokota M; Nishida T; Maruyama T; Ohshima T
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1031-5. PubMed ID: 18854179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polycomb protein Pc2 is a SUMO E3.
    Kagey MH; Melhuish TA; Wotton D
    Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net.
    Wasylyk C; Criqui-Filipe P; Wasylyk B
    Oncogene; 2005 Jan; 24(5):820-8. PubMed ID: 15580297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
    Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation by C-terminal binding proteins.
    Chinnadurai G
    Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
    Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
    Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription.
    Tiefenbach J; Novac N; Ducasse M; Eck M; Melchior F; Heinzel T
    Mol Biol Cell; 2006 Apr; 17(4):1643-51. PubMed ID: 16421255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.
    Kuo HY; Chang CC; Jeng JC; Hu HM; Lin DY; Maul GG; Kwok RP; Shih HM
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16973-8. PubMed ID: 16287980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple activities contribute to Pc2 E3 function.
    Kagey MH; Melhuish TA; Powers SE; Wotton D
    EMBO J; 2005 Jan; 24(1):108-19. PubMed ID: 15592428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
    Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
    Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumoylation of Drosophila transcription factor STAT92E.
    Grönholm J; Ungureanu D; Vanhatupa S; Rämet M; Silvennoinen O
    J Innate Immun; 2010; 2(6):618-24. PubMed ID: 20616536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver receptor homolog-1 localization in the nuclear body is regulated by sumoylation and cAMP signaling in rat granulosa cells.
    Yang FM; Pan CT; Tsai HM; Chiu TW; Wu ML; Hu MC
    FEBS J; 2009 Jan; 276(2):425-36. PubMed ID: 19125815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.